(19)
(11) EP 3 288 961 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
27.04.2022 Bulletin 2022/17

(45) Mention of the grant of the patent:
24.11.2021 Bulletin 2021/47

(21) Application number: 16785833.1

(22) Date of filing: 14.04.2016
(51) International Patent Classification (IPC): 
C07K 7/06(2006.01)
A61P 27/00(2006.01)
C07K 14/00(2006.01)
A61P 25/28(2006.01)
A61K 38/00(2006.01)
A61K 38/08(2019.01)
A61P 35/00(2006.01)
A61P 11/00(2006.01)
A61P 31/04(2006.01)
A61P 37/08(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 7/06; C07K 14/001; A61K 38/00; A61P 37/08; A61K 38/08
(86) International application number:
PCT/CN2016/079300
(87) International publication number:
WO 2016/173402 (03.11.2016 Gazette 2016/44)

(54)

SHORT SYNTHETIC PEPTIDE FOR TREATING DISEASES AND/OR CONDITIONS RELATED TO ANGIOGENESIS

KURZES SYNTHETISCHES PEPTID ZUR BEHANDLUNG VON ANGIOGENESEBEDINGTEN ERKRANKUNGEN UND/ODER ZUSTÄNDEN

PEPTIDE SYNTHÉTIQUE COURT POUR LE TRAITEMENT DE MALADIES ET/OU CONDITIONS LIÉES À L'ANGIOGENÈSE


(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 27.04.2015 US 201562152980 P

(43) Date of publication of application:
07.03.2018 Bulletin 2018/10

(73) Proprietor: MacKay Memorial Hospital
Taipei City 104 (TW)

(72) Inventors:
  • TSAO, Yeou-Ping
    Taipei City, Taiwan 104 (CN)
  • HO, Tsung-Chuan
    Taipei City Taiwan 104 (CN)

(74) Representative: Lang, Christian 
LangPatent Anwaltskanzlei IP Law Firm Ingolstädter Straße 5
80807 München
80807 München (DE)


(56) References cited: : 
WO-A1-2004/028559
WO-A2-02/098351
CN-A- 103 897 038
WO-A1-2014/037332
CN-A- 1 699 408
US-A1- 2010 331 263
   
  • CHRISTINE PIOSSEK ET AL: "Summary", THROMBOSIS AND HAEMOSTASIS, vol. 90, no. 09, 1 January 2003 (2003-01-01), pages 501-510, XP055523436, DE ISSN: 0340-6245, DOI: 10.1160/TH03-02-0106
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).